Sanofi (SNY) Treasury Shares (2009 - 2021)

Sanofi's (SNY) quarterly Treasury Shares came in at -$839.4 million in Q2 2021, down 156.97% quarter-over-quarter from -$326.6 million in Q4 2015.

Sanofi (SNY) Treasury Shares (2009 - 2021) Analysis & Trends

Sanofi has disclosed Treasury Shares across 4 years of filings, most recently posting -$839.4 million for Q2 2021.

Treasury Shares for Q2 2021 came in at -$839.4 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2021 was -$839.4 million (changed N/A YoY), and the FY2015 annual result was -$331.0 million, changed N/A from the prior year.
Treasury Shares came in at -$839.4 million for Q2 2021 at Sanofi, down from -$326.6 million in the prior quarter.
In the past five years, Treasury Shares ranged from a high of -$839.4 million in Q2 2021 to a low of -$839.4 million in Q2 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Gsk	93,699,046.73 Bn	93,699,041.77 Bn	7.76 Bn	-
2	Eli Lilly	1,012.06 Bn	1,006.77 Bn	16.22 Bn	3.01 Bn
3	Johnson & Johnson	560.67 Bn	538.62 Bn	15.96 Bn	76.26 Bn
4	AbbVie	402.20 Bn	392.85 Bn	10.78 Bn	77.08 Mn
5	Merck	298.59 Bn	292.94 Bn	12.09 Bn	1.11 Bn
6	Amgen	188.77 Bn	176.74 Bn	5.87 Bn	-
7	Gilead Sciences	160.22 Bn	152.49 Bn	5.52 Bn	-
8	Pfizer	148.19 Bn	135.42 Bn	-1.21 Bn	3.94 Bn
9	Bristol Myers Squibb	116.72 Bn	106.26 Bn	8.07 Bn	881.00 Mn
10	Sanofi	63.47 Mn	-6.87 Bn	9.49 Bn	-

Download Data